Literature DB >> 18676160

Phenobarbital withdrawal seizures may occur over several weeks before remitting: human data and hypothetical mechanism.

Jean M Bidlack1, Harold H Morris.   

Abstract

This case is the first report of a patient who had phenobarbital (PB) withdrawal seizures after having been seizure-free for 3 years following temporal lobe surgery. The patient had been taking PB for 14 years when a gradual taper of PB was started. When PB was at 60 mg/d, a titration of lamotrigine (LTG) was started. However, typical complex seizures occurred when the patient was on PB 60 mg/d, along with LTG 25mg/d. PB was increased back to 90 mg/d and levetiracetam (LEV) was titrated. Seizures appeared when the patient was on PB 30 mg/d and LEV 750 mg BID and continued for 3 weeks after PB was stopped and the patient was on LEV 1,000 mg BID. For the following 6 months, her aura frequency remained elevated in comparison to her baseline aura of two auras per month for the previous year before the start of the PB taper. She was followed for 24 months after her last PB withdrawal seizure. During the last 8 months, her aura frequency returned to her baseline. As suggested by animal studies, the PB withdrawal seizures and increase in aura frequency in this patient may be explained by changes in her levels of GABA(A) receptor subunits.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676160      PMCID: PMC2632796          DOI: 10.1016/j.seizure.2008.06.014

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  15 in total

1.  Ubiquitination, proteasomes and GABA(A) receptors.

Authors:  B Lüscher; C A Keller
Journal:  Nat Cell Biol       Date:  2001-10       Impact factor: 28.824

2.  Benzodiazepine dependency syndromes.

Authors:  D E Smith; D R Wesson
Journal:  J Psychoactive Drugs       Date:  1983 Jan-Jun

Review 3.  Protracted withdrawal syndromes from benzodiazepines.

Authors:  H Ashton
Journal:  J Subst Abuse Treat       Date:  1991

4.  Long-term effects of diazepam and phenobarbital treatment during development on GABA receptors, transporters and glutamic acid decarboxylase.

Authors:  Y H Raol; G Zhang; E C Budreck; A R Brooks-Kayal
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

5.  Risk of extremity fractures in adult outpatients with epilepsy.

Authors:  Hakan B I Persson; K A Alberts; B Y Farahmand; T Tomson
Journal:  Epilepsia       Date:  2002-07       Impact factor: 5.864

6.  Characteristic changes of the GABAA receptor in the brain of phenobarbital-dependent and withdrawn rats.

Authors:  S Tanaka; K Aoki; T Satoh; T Yoshida; Y Kuroiwa
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1991-09

7.  Seizures during barbiturate withdrawal: relation to blood level.

Authors:  W H Theodore; R J Porter; R F Raubertas
Journal:  Ann Neurol       Date:  1987-11       Impact factor: 10.422

Review 8.  Neurosteroid regulation of GABA(A) receptors: Focus on the alpha4 and delta subunits.

Authors:  Sheryl S Smith; Hui Shen; Qi Hua Gong; Xiangping Zhou
Journal:  Pharmacol Ther       Date:  2007-04-21       Impact factor: 12.310

Review 9.  Epilepsy and bone health in adults.

Authors:  Alison M Pack; Martha J Morrell
Journal:  Epilepsy Behav       Date:  2004-02       Impact factor: 2.937

10.  Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy.

Authors:  A R Brooks-Kayal; M D Shumate; H Jin; T Y Rikhter; D A Coulter
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

View more
  1 in total

Review 1.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.